MedTrace Logo

The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients

NCT03067194 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2020-01-30

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy and safety of Celecoxib capsule in hand osteoarthritis patients.

Conditions

  • Osteoarthritis Hand

Interventions

DRUG

Celecoxib 100 MG

Celecoxib 100mg, Oral, BID(twice per day), During 6 weeks

DRUG

Celecoxib 200mg

Celecoxib 200mg, Oral, QD(once daily), During 6 weeks

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Hyun Sook Kim · Soonchunhyang University Hospital

  • Chan Hong Jeon · Soonchunhyang University Hospital

  • Sung Hae Jang · Soonchunhyang University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-27
Primary Completion
2017-07-10
Completion
2018-11-20

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03067194 on ClinicalTrials.gov